Andreas Maetzel

4.4k total citations · 1 hit paper
61 papers, 3.3k citations indexed

About

Andreas Maetzel is a scholar working on Rheumatology, Economics and Econometrics and Immunology. According to data from OpenAlex, Andreas Maetzel has authored 61 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 16 papers in Economics and Econometrics and 13 papers in Immunology. Recurrent topics in Andreas Maetzel's work include Rheumatoid Arthritis Research and Therapies (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Biosimilars and Bioanalytical Methods (9 papers). Andreas Maetzel is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Biosimilars and Bioanalytical Methods (9 papers). Andreas Maetzel collaborates with scholars based in Canada, United States and Switzerland. Andreas Maetzel's co-authors include Linda Li, Claire Bombardier, Peter Tugwell, Robert W. Norman, Harry S. Shannon, Richard Wells, Ann‐Sylvia Brooker, John Frank, Mickey Kerr and George A. Wells and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Bone and Joint Surgery.

In The Last Decade

Andreas Maetzel

60 papers receiving 3.2k citations

Hit Papers

Disability Resulting From Occupational Low Back Pain 1996 2026 2006 2016 1996 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Disability Resulting From Occupational Low Back Pain
    1996 481 citations John Frank, Ann‐Sylvia Brooker et al. Spine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Maetzel Canada 29 1.4k 1.2k 516 514 410 61 3.3k
Glen Hazlewood Canada 26 166 0.1× 1.3k 1.0× 278 0.5× 485 0.9× 313 0.8× 157 3.9k
Fraser Birrell United Kingdom 29 578 0.4× 1.3k 1.1× 192 0.4× 1.1k 2.1× 117 0.3× 71 2.8k
Edward Roddy United Kingdom 44 761 0.6× 2.6k 2.2× 696 1.3× 2.6k 5.0× 266 0.6× 209 7.7k
Robert H. Shmerling United States 23 361 0.3× 691 0.6× 126 0.2× 472 0.9× 166 0.4× 67 2.0k
Anne M. Rentz United States 38 210 0.2× 267 0.2× 100 0.2× 1.0k 2.0× 388 0.9× 74 4.3k
Cindy J. Wong Canada 30 95 0.1× 308 0.3× 151 0.3× 1.4k 2.8× 259 0.6× 47 4.5k
Curtis J. Henke United States 19 194 0.1× 512 0.4× 127 0.2× 231 0.4× 314 0.8× 30 1.6k
Patricia Clark Mexico 27 226 0.2× 343 0.3× 383 0.7× 740 1.4× 140 0.3× 140 2.9k
David Watters Australia 30 108 0.1× 371 0.3× 172 0.3× 1.2k 2.2× 243 0.6× 188 4.0k
Kiichiro Tsutani Japan 25 149 0.1× 205 0.2× 112 0.2× 213 0.4× 205 0.5× 125 2.6k

Countries citing papers authored by Andreas Maetzel

Since Specialization
Citations

This map shows the geographic impact of Andreas Maetzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Maetzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Maetzel more than expected).

Fields of papers citing papers by Andreas Maetzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Maetzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Maetzel. The network helps show where Andreas Maetzel may publish in the future.

Co-authorship network of co-authors of Andreas Maetzel

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Maetzel. A scholar is included among the top collaborators of Andreas Maetzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Maetzel. Andreas Maetzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riedl, Marc A., et al.. (2023). Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns. The Journal of Allergy and Clinical Immunology In Practice. 11(8). 2450–2456.e6. 17 indexed citations
2.
Sun, Jennifer K., Raj K. Maturi, David S. Boyer, et al.. (2019). One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision. Ophthalmology Retina. 3(12). 1107–1109. 12 indexed citations
3.
4.
5.
Sander, Beate, Jeffrey C. Kwong, Chris T. Bauch, et al.. (2010). Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis. PLoS Medicine. 7(4). e1000256–e1000256. 56 indexed citations
6.
Boonen, Annelies, Andreas Maetzel, Michael Drummond, et al.. (2009). The OMERACT Initiative. Towards a Reference Approach to Derive QALY for Economic Evaluations in Rheumatology. The Journal of Rheumatology. 36(9). 2045–2049. 9 indexed citations
7.
Clark, Patricia, F. Carlos, Andreas Maetzel, et al.. (2007). Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system. Osteoporosis International. 19(3). 269–276. 37 indexed citations
8.
Maetzel, Andreas. (2005). Cost-effectiveness estimates reported for tumor necrosis factor blocking agents in rheumatoid arthritis refractory to methotrexate--a brief summary.. PubMed. 72. 51–3. 2 indexed citations
9.
10.
Rüttimann, S, et al.. (2004). Long‐Term Antibiotic Cost Savings from a Comprehensive Intervention Program in a Medical Department of a University‐Affiliated Teaching Hospital. Clinical Infectious Diseases. 38(3). 348–356. 121 indexed citations
11.
Maetzel, Andreas, Murray Krahn, & Gary Naglie. (2003). The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Arthritis Care & Research. 49(3). 283–292. 83 indexed citations
12.
Maetzel, Andreas & Linda Li. (2002). The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Practice & Research Clinical Rheumatology. 16(1). 23–30. 332 indexed citations
13.
Maetzel, Andreas, Vibeke Strand, Peter Tugwell, George A. Wells, & Claire Bombardier. (2002). Cost effectiveness of adding leflunomide to a 5‐year strategy of conventional disease‐modifying antirheumatic drugs in patients with rheumatoid arthritis. Arthritis Care & Research. 47(6). 655–661. 25 indexed citations
14.
Maetzel, Andreas. (2000). Use of grade membership analysis to profile the practice styles of individual physicians in the management of acute low back pain. Journal of Clinical Epidemiology. 53(2). 195–205. 10 indexed citations
15.
Maetzel, Andreas, et al.. (2000). Meta‐analysis of treatment termination rates among rheumatoid arthritis patients receiving disease‐modifying anti‐rheumatic drugs. Lara D. Veeken. 39(9). 975–981. 146 indexed citations
16.
Strand, Vibeke, Peter Tugwell, Claire Bombardier, et al.. (1999). Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Arthritis & Rheumatism. 42(9). 1870–1878. 111 indexed citations
17.
Maetzel, Andreas, Marcos Bosi Ferraz, & Claire Bombardier. (1998). A review of cost-effectiveness analyses in rheumatology and related disciplines. Current Opinion in Rheumatology. 10(2). 136–140. 16 indexed citations
18.
Maetzel, Andreas, et al.. (1997). Osteoarthritis of the hip and knee and mechanical occupational exposure - A systematic overview of the evidence. 5(37). 234. 19 indexed citations
19.
Frank, John, Mickey Kerr, Ann‐Sylvia Brooker, et al.. (1996). Disability Resulting From Occupational Low Back Pain. Spine. 21(24). 2908–2917. 220 indexed citations
20.
Frank, John, Ann‐Sylvia Brooker, Mickey Kerr, et al.. (1996). Disability Resulting From Occupational Low Back Pain. Spine. 21(24). 2918–2929. 481 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glen Hazlewood Breakdown of academic impact, for papers by Fraser Birrell Breakdown of academic impact, for papers by Edward Roddy Breakdown of academic impact, for papers by Robert H. Shmerling Breakdown of academic impact, for papers by Anne M. Rentz Breakdown of academic impact, for papers by Cindy J. Wong Breakdown of academic impact, for papers by Curtis J. Henke Breakdown of academic impact, for papers by Patricia Clark Breakdown of academic impact, for papers by David Watters Breakdown of academic impact, for papers by Kiichiro Tsutani
Rankless by CCL
2026